Schedule 13G ownership disclosure

Castle Biosciences Inc

Common Stock, $0.001 par value per share · CUSIP: 14843C105

Event date: 2026-09-30

Filing-level shares
1,500,897
Percent of class
4.9%
  • PRINCIPAL GLOBAL INVESTORS

    Shares: 1,500,897 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769734-26-000056
Form type
SCHEDULE 13G/A
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Oct 29, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub